148 related articles for article (PubMed ID: 9823338)
1. The presence of a constitutively active phosphoinositide 3-kinase in small cell lung cancer cells mediates anchorage-independent proliferation via a protein kinase B and p70s6k-dependent pathway.
Moore SM; Rintoul RC; Walker TR; Chilvers ER; Haslett C; Sethi T
Cancer Res; 1998 Nov; 58(22):5239-47. PubMed ID: 9823338
[TBL] [Abstract][Full Text] [Related]
2. Regulation of cellular proliferation, cytoskeletal function, and signal transduction through CXCR4 and c-Kit in small cell lung cancer cells.
Kijima T; Maulik G; Ma PC; Tibaldi EV; Turner RE; Rollins B; Sattler M; Johnson BE; Salgia R
Cancer Res; 2002 Nov; 62(21):6304-11. PubMed ID: 12414661
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of akt/protein kinase B signaling by naltrindole in small cell lung cancer cells.
Chen YL; Law PY; Loh HH
Cancer Res; 2004 Dec; 64(23):8723-30. PubMed ID: 15574783
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of the phosphatidylinositol 3-kinase/Akt/mammalian target of rapamycin pathway but not the MEK/ERK pathway attenuates laminin-mediated small cell lung cancer cellular survival and resistance to imatinib mesylate or chemotherapy.
Tsurutani J; West KA; Sayyah J; Gills JJ; Dennis PA
Cancer Res; 2005 Sep; 65(18):8423-32. PubMed ID: 16166321
[TBL] [Abstract][Full Text] [Related]
5. Activation of phosphatidylinositol 3-kinase, protein kinase B, and p70 S6 kinases in lipopolysaccharide-stimulated Raw 264.7 cells: differential effects of rapamycin, Ly294002, and wortmannin on nitric oxide production.
Salh B; Wagey R; Marotta A; Tao JS; Pelech S
J Immunol; 1998 Dec; 161(12):6947-54. PubMed ID: 9862729
[TBL] [Abstract][Full Text] [Related]
6. Cooperative effect of hepatocyte growth factor and fibronectin in anchorage-independent survival of mammary carcinoma cells: requirement for phosphatidylinositol 3-kinase activity.
Qiao H; Saulnier R; Patryzkat A; Rahimi N; Raptis L; Rossiter J; Tremblay E; Elliott B
Cell Growth Differ; 2000 Feb; 11(2):123-33. PubMed ID: 10714768
[TBL] [Abstract][Full Text] [Related]
7. Akt/protein kinase B is constitutively active in non-small cell lung cancer cells and promotes cellular survival and resistance to chemotherapy and radiation.
Brognard J; Clark AS; Ni Y; Dennis PA
Cancer Res; 2001 May; 61(10):3986-97. PubMed ID: 11358816
[TBL] [Abstract][Full Text] [Related]
8. Growth inhibition and modulation of kinase pathways of small cell lung cancer cell lines by the novel tyrosine kinase inhibitor STI 571.
Wang WL; Healy ME; Sattler M; Verma S; Lin J; Maulik G; Stiles CD; Griffin JD; Johnson BE; Salgia R
Oncogene; 2000 Jul; 19(31):3521-8. PubMed ID: 10918610
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of phosphatidylinositol 3-kinase-Akt signaling blocks growth, promotes apoptosis, and enhances sensitivity of small cell lung cancer cells to chemotherapy.
Krystal GW; Sulanke G; Litz J
Mol Cancer Ther; 2002 Sep; 1(11):913-22. PubMed ID: 12481412
[TBL] [Abstract][Full Text] [Related]
10. Activated c-Met signals through PI3K with dramatic effects on cytoskeletal functions in small cell lung cancer.
Maulik G; Madhiwala P; Brooks S; Ma PC; Kijima T; Tibaldi EV; Schaefer E; Parmar K; Salgia R
J Cell Mol Med; 2002; 6(4):539-53. PubMed ID: 12611639
[TBL] [Abstract][Full Text] [Related]
11. In vitro chemo- and radio-resistance in small cell lung cancer correlates with cell adhesion and constitutive activation of AKT and MAP kinase pathways.
Kraus AC; Ferber I; Bachmann SO; Specht H; Wimmel A; Gross MW; Schlegel J; Suske G; Schuermann M
Oncogene; 2002 Dec; 21(57):8683-95. PubMed ID: 12483521
[TBL] [Abstract][Full Text] [Related]
12. Matrix adhesion and Ras transformation both activate a phosphoinositide 3-OH kinase and protein kinase B/Akt cellular survival pathway.
Khwaja A; Rodriguez-Viciana P; Wennström S; Warne PH; Downward J
EMBO J; 1997 May; 16(10):2783-93. PubMed ID: 9184223
[TBL] [Abstract][Full Text] [Related]
13. Insulin-induced Drosophila S6 kinase activation requires phosphoinositide 3-kinase and protein kinase B.
Lizcano JM; Alrubaie S; Kieloch A; Deak M; Leevers SJ; Alessi DR
Biochem J; 2003 Sep; 374(Pt 2):297-306. PubMed ID: 12841848
[TBL] [Abstract][Full Text] [Related]
14. Essential role of Pyk2 and Src kinase activation in neuropeptide-induced proliferation of small cell lung cancer cells.
Roelle S; Grosse R; Buech T; Chubanov V; Gudermann T
Oncogene; 2008 Mar; 27(12):1737-48. PubMed ID: 17906699
[TBL] [Abstract][Full Text] [Related]
15. Tyrosine kinase-dependent, phosphatidylinositol 3'-kinase, and mitogen-activated protein kinase-independent signaling pathways prevent lung adenocarcinoma cells from anoikis.
Wei L; Yang Y; Yu Q
Cancer Res; 2001 Mar; 61(6):2439-44. PubMed ID: 11289112
[TBL] [Abstract][Full Text] [Related]
16. Galanin, neurotensin, and phorbol esters rapidly stimulate activation of mitogen-activated protein kinase in small cell lung cancer cells.
Seufferlein T; Rozengurt E
Cancer Res; 1996 Dec; 56(24):5758-64. PubMed ID: 8971188
[TBL] [Abstract][Full Text] [Related]
17. Lovastatin inhibits the growth and survival pathway of phosphoinositide 3-kinase/protein kinase B in immortalized rat brain neuroblasts.
Cerezo-Guisado MI; Garcia-Marin LJ; Lorenzo MJ; Bragado MJ
J Neurochem; 2005 Sep; 94(5):1277-87. PubMed ID: 16111478
[TBL] [Abstract][Full Text] [Related]
18. Constitutive activation of p70 S6 kinase is associated with intrinsic resistance to cisplatin.
Dhar R; Basu A
Int J Oncol; 2008 May; 32(5):1133-7. PubMed ID: 18425342
[TBL] [Abstract][Full Text] [Related]
19. Mechanism of phosphatidylinositol 3-kinase-dependent increases in BAC1.2F5 macrophage-like cell density in response to M-CSF: phosphatidylinositol 3-kinase inhibitors increase the rate of apoptosis rather than inhibit DNA synthesis.
Murray JT; Craggs G; Wilson L; Kellie S
Inflamm Res; 2000 Nov; 49(11):610-8. PubMed ID: 11131301
[TBL] [Abstract][Full Text] [Related]
20. Potent inhibition of small-cell lung cancer cell growth by simvastatin reveals selective functions of Ras isoforms in growth factor signalling.
Khanzada UK; Pardo OE; Meier C; Downward J; Seckl MJ; Arcaro A
Oncogene; 2006 Feb; 25(6):877-87. PubMed ID: 16170339
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]